Cargando…
CD44 Targeted Nanomaterials for Treatment of Triple-Negative Breast Cancer
SIMPLE SUMMARY: Triple-negative breast cancer (TNBC) is one of the most challenging tumors with aggressive behavior, low recovery rate, poor prognosis, high metastatic potential, and rapid relapse compared to other breast cancer subtypes. Conventional therapies currently have minimal effect on TNBC;...
Autores principales: | Nabil, Ghazal, Alzhrani, Rami, Alsaab, Hashem O., Atef, Mohammed, Sau, Samaresh, Iyer, Arun K., Banna, Hossny El |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924562/ https://www.ncbi.nlm.nih.gov/pubmed/33672756 http://dx.doi.org/10.3390/cancers13040898 |
Ejemplares similares
-
Folate Decorated Nanomicelles Loaded with a Potent Curcumin Analogue for Targeting Retinoblastoma
por: Alsaab, Hashem, et al.
Publicado: (2017) -
PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
por: Alsaab, Hashem O., et al.
Publicado: (2017) -
Progress in Clinical Trials of Photodynamic Therapy for Solid Tumors and the Role of Nanomedicine
por: Alsaab, Hashem O., et al.
Publicado: (2020) -
Development of asialoglycoprotein receptor directed nanoparticles for selective delivery of curcumin derivative to hepatocellular carcinoma
por: Yousef, Shaimaa, et al.
Publicado: (2018) -
PDL-1 Antibody Drug Conjugate for Selective Chemo-Guided Immune Modulation of Cancer
por: Sau, Samaresh, et al.
Publicado: (2019)